Carmen M. Alonso-Gamboa

Nuevo Repueblo, NLE, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Evolution of clinical, histological and serological features in a Primary Sjὄgren´s Syndrome cohort and the limitations of the current classification criteria.

Evolution of clinical, histological and serological features in a Primary Sjὄgren´s Syndrome cohort and the limitations of the current classification criteria.

Journal: Acta reumatologica portuguesa

Published: December 28, 2021

Vaccination in rheumatic disease patients: results of a pilot quality improvement program.

Vaccination in rheumatic disease patients: results of a pilot quality improvement program.

Journal: Reumatologia

Published: May 21, 2021

Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.

Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.

Journal: Human vaccines & immunotherapeutics

Published: September 29, 2020

Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al.

Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al.

Journal: Annals of the rheumatic diseases

Published: June 09, 2020

Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al.

Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al.

Journal: Annals of the rheumatic diseases

Published: June 09, 2020

Are my patients with rheumatic diseases at higher risk of COVID-19?

Are my patients with rheumatic diseases at higher risk of COVID-19?

Journal: Annals of the rheumatic diseases

Published: March 11, 2020

2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine.

2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine.

Journal: Annals of the rheumatic diseases

Published: May 13, 2019

High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.

High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.

Journal: Revista brasileira de hematologia e hemoterapia

Published: May 10, 2017

TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse.

TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse.

Journal: Blood cells, molecules & diseases

Published: November 18, 2016

Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Journal: Acta haematologica

Published: October 11, 2016

Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.

Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.

Journal: Archives of medical research

Published: February 12, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026